Amesh Adalja, MD
Infectious Disease · Pittsburgh, PANPI 1023209871
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $256,235 of the $415,216 with a category attached, or 61.7%. 17 manufacturers reported payments, led by GSK at 37.8% of the total. Reporting peaked in 2023 at $140,607 and has fallen 53.6% since, to $65,281 in 2025. Among infectious disease clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 438 payments — averaging $947.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$157K
- Merck$150K
- Sanofi Pasteur Inc.$18K
- Shionogi Inc$16K
- Pfizer$14K
- Emergent Biosolutions Inc.$12K
- plus $48K from 11 others
What the payments were for
- Consulting fees$98,23624%
- Speaking & faculty fees$256,23562%
- Travel & lodging$51,07212%
- Food & beverage$9,6742%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 131 | $157,057 |
| Merck | 218 | $150,218 |
| Sanofi Pasteur Inc. | 10 | $17,647 |
| Shionogi Inc | 18 | $15,752 |
| Pfizer | 12 | $13,866 |
| Emergent Biosolutions Inc. | 4 | $12,350 |
| Henry Schein, Inc. | 11 | $12,300 |
| BD | 11 | $7,030 |
| Invivyd Inc | 3 | $6,716 |
| Seqirus USA Inc | 4 | $6,029 |
| Modernatx, Inc. | 3 | $5,690 |
| Siemens Medical Solutions USA, Inc. | 1 | $3,000 |
| Biomerieux Inc | 2 | $2,983 |
| Janssen Scientific Affairs, LLC | 1 | $2,020 |
| Melinta Therapeutics, LLC | 6 | $1,033 |
| AstraZeneca | 1 | $910 |
| AbbVie | 2 | $617 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$415,216 in reported general payments places this provider in the 95th percentile of 457 infectious disease providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Pittsburgh
- Micah JacobsPittsburgh$206K
- Brandon SmithPittsburgh$108K
- Lee HarrisonPittsburgh$70K
- Yohei DoiPittsburgh$67K
- Chiu Bin HsiaoPittsburgh$33K
- Minh-Hong NguyenPittsburgh$20K
- Ghady HaidarPittsburgh$19K
- Thomas WalshPittsburgh$10K
- Fernanda SilveiraPittsburgh$7K
- Stacy LanePittsburgh$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.